-
1 Comment
Sartorius Aktiengesellschaft is currently in a long term uptrend where the price is trading 24.9% above its 200 day moving average.
From a valuation standpoint, the stock is 99.2% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 10.9.
Sartorius Aktiengesellschaft's total revenue rose by 39.2% to $656M since the same quarter in the previous year.
Its net income has increased by 117.7% to $77M since the same quarter in the previous year.
Finally, its free cash flow fell by 60.8% to $26M since the same quarter in the previous year.
Based on the above factors, Sartorius Aktiengesellschaft gets an overall score of 4/5.
| Exchange | F |
|---|---|
| CurrencyCode | EUR |
| Sector | Healthcare |
| ISIN | DE0007165607 |
| Industry | Medical Instruments & Supplies |
| Target Price | 254.1072 |
|---|---|
| Dividend Yield | 0.4% |
| Beta | 1.51 |
| Market Cap | 12B |
| PE Ratio | 75.36 |
Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers analytical solutions, such as biolayer interferometry systems, high-throughput screening by cytometry systems, process analytical technology and data analytics, cell selection and retrieval, live-cell imaging and analysis systems, and surface plasmon resonance systems; cell culture solutions, including bioreactors and fermenters, cell culture reagents, supplements and matrices, nucleic acid and delivery solutions, cell culture media, and cell lines and buffers; and fluid management products. It also provides lab filtration and purification solutions, lab water purification systems, microtissue technologies, lab weighing, pipettes, tips and dispensers, microbiological testing solutions, lab data and fleet management software, and OEM solutions; and Process chromatography and filtration solutions. The company serves the life science research, biopharmaceutical manufacturing, cell and gene therapy, and applied industries. The company was founded in 1870 and is headquartered in Göttingen, Germany.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for SRT.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2026